Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273

JAMA. 2021 Oct 19;326(15):1533-1535. doi: 10.1001/jama.2021.15125.

Abstract

This study compares the immune responses to the BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) COVID-19 vaccines in health care workers in Belgium.

Publication types

  • Comparative Study

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • Adult
  • Antibodies, Viral*
  • Antibody Formation / immunology
  • BNT162 Vaccine
  • COVID-19 / immunology*
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / immunology*
  • Female
  • Health Personnel
  • Humans
  • Male
  • Prospective Studies
  • SARS-CoV-2 / immunology*
  • Vaccination

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • 2019-nCoV Vaccine mRNA-1273
  • BNT162 Vaccine